Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_890_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •A Formal Introduction
- •The Physical Examination
- •Conveying Pathology Results
- •The Team and Teaching
- •The Team’s Role
- •Educational and Informational Resources for Patients
- •Support Groups and Personal Resources
- •Counseling and Consent
- •Physical, Psychological, or Language Barriers
- •The Internet: A Double-Edged Sword
- •1: The First Encounter
- •Introduction
- •Prior to the Encounter
- •The Initial Encounter
- •Navigating a Litany “To Dos”
- •Preemptive Discussion of Potential Complications
- •The Patient’s Family
- •Communicating with Other Physicians
- •Conclusion
- •Summary Pearls
- •References
- •2: Perioperative Risk Assessment
- •Introduction
- •The Healthy Patient
- •Exercise Tolerance
- •Social Habits
- •Medications
- •Anesthetic Issues
- •Preoperative Testing
- •The Comorbid Patient
- •Consultation
- •Cardiovascular Risk Assessment and Risk Reduction
- •Pulmonary Risk Assessment and Risk Reduction
- •Chronic Renal Failure Risk Assessment and Risk Reduction
- •Diabetes Mellitus Risk Assessment and Risk Reduction
- •Hepatic Failure Risk Assessment and Risk Reduction
- •Surgical Site Infection (SSI) Risk Assessment and Reduction
- •Anastomotic Leak: Risk Assessment and Risk Reduction
- •Risk Evaluation and Informed Consent
- •Summary Pearls
- •References
- •3: Perioperative Nutrition Support in Colorectal Surgery
- •Introduction
- •Prevalence and Impact of Malnutrition
- •Patient Assessment
- •Albumin
- •Nitrogen Balance
- •Cancer Cachexia
- •Initiation of Nutritional Support
- •Nutritional Options: Enteral and Parenteral
- •Enteral Feeding
- •Early Enteral Feeding Versus NPO
- •Enteral Shortcomings
- •Aspiration
- •Feeding Tolerance
- •Enteral Complications
- •Total Parenteral Nutrition
- •Complications
- •Catheter
- •Metabolic
- •How to Write TPN
- •Enteral Versus Parenteral
- •Perioperative Management
- •Immunonutrition
- •Total Parenteral Nutrition
- •Postoperative Management
- •Summary/Pearls
- •References
- •4: Diverticulitis: Beyond the Basics
- •Introduction
- •Indications for Surgery
- •Indications for Surgery: Uncomplicated Diverticulitis
- •Risk of Subsequent Attacks of Diverticulitis After Recovery from Uncomplicated Diverticulitis
- •Risk of Developing Complicated Diverticulitis After Recovery from an Attack of Uncomplicated Diverticulitis
- •Risk of Developing Free Perforation/Risk of Requiring Emergency Surgery and Stoma After Recovery from an Episode of Uncomplicated Diverticulitis
- •Smoldering Versus Discrete Attacks of Diverticulitis
- •Severity of Disease and Indications for Surgery
- •Other Considerations in Recommending Resection
- •Risk of Recurrent Diverticulitis After Resection
- •Young Patients and Diverticulitis
- •Laparoscopy and Indications for Surgery
- •Nonoperative Management and Non-resective Treatment
- •My Recommendations for Elective Resection in the Setting of Uncomplicated Disease
- •Complicated Diverticulitis
- •Diverticular Fistulas
- •Diverticular Stricture
- •Diverticular Abscess
- •Patient Positioning
- •Approach to the Procedure
- •Exposure and Lighting
- •Initial Dissection
- •Performing the Anastomosis
- •Alternatives
- •Abdominal Wall Closure
- •Reoperation for Sepsis and Anastomotic Complications After Hartmann Takedown
- •Reoperation for Recurrent Diverticulitis
- •Conclusion
- •Summary Pearls
- •References
- •5: Carcinomatosis: Cytoreduction and Heated Intraperitoneal Chemotherapy (HIPEC) Versus Palliation
- •Perforated Diverticulitis with Purulent or Feculent Peritonitis
- •Reoperative Surgery for Diverticular Disease
- •Reoperative Surgery After Hartmann Resection
- •Timing
- •Preoperative Preparation
- •Preoperative Imaging
- •Intraoperative Considerations
- •Background, Basics, and Rationale
- •General Aspects, Epidemiology
- •Change of Paradigm
- •Anatomy and Embryology
- •History and Rationale for Intraperitoneal Drug Therapy
- •Peritoneal Cancer Index (PCI)
- •HIPEC: Technique, Rationale, and Drugs
- •Multimodal Therapy in Peritoneal Carcinomatosis
- •Second Look Concept
- •Decision Making/Preoperative Work-up
- •Indications and Interdisciplinary Tumor Board
- •Contraindications
- •Quantitative Prognostic Factors (QPIs)
- •Ethical Considerations
- •Intraoperative Work-up
- •Cytoreductive Surgery: Logistics, Strategy, and Technique
- •Oncological Planning
- •Technical Planning
- •Surgical Planning
- •Type of Disease
- •Extent and Location of Disease
- •Approach to “Critical Lesions”
- •Abdominal Wall Assessment
- •Approach to Liver Metastasis
- •HIPEC Planning
- •Anesthesia Planning
- •Nutritional Planning
- •Stoma Planning
- •Perioperative Antibiotic Prophylaxis
- •Venous Thromboembolism Prophylaxis
- •Mechanical Bowel Preparation
- •Skin Preparation
- •Operating Room
- •Induction of Anesthesia and Monitoring
- •Surgical Technique
- •Perioperative Chemotherapy
- •Early Postoperative Intraperitoneal Chemotherapy (EPIC)
- •Complete CRS Not Achievable: What Now?
- •Postoperative Considerations
- •Morbidity and Mortality
- •Complication Management and Patient Follow-Up
- •Pearls and Practical Tips in Peritoneal Cytoreductive Surgery
- •References
- •6: Metastatic Colorectal Cancer
- •Introduction
- •Multidisciplinary Approach
- •Evolution of Care
- •Indications for Operation
- •Should I Biopsy the Metastasis?
- •What Should I Do with the Primary Lesion in the Patient with Extensive Disease?
- •What Treatment Modality Should Come First?
- •The Obstructed Patient: What Now?
- •Liver
- •Lung
- •Peritoneal Metastases
- •Ovary
- •Brain
- •Controversial Points
- •The Patient with a “Near Obstruction”
- •Role of Radiation for Rectal Cancer in Patients with Stage 4 Disease
- •Technical Pearls
- •Salvage Operation
- •Palliative Care
- •Summary Pearls
- •References
- •7: Enterocutaneous Fistulas
- •Initial Evaluation
- •Controlling Sepsis
- •Managing Patient Expectations and the Importance of “Patience”
- •Evaluation of the Fistula
- •Nutritional Support
- •Postoperative Nutrition
- •Rehabilitation Phase
- •How to Control Fistula Output and Role of Adjunctive Medications
- •Creative Ways for Wound Care
- •Dealing with Medications for Underlying Disease
- •Surgical Evaluation
- •Spontaneous Closure or Not?
- •Timing of Operation
- •Reviewing the Prior Operative Notes: Does It Help?
- •Techniques
- •Preoperative Preparation
- •Surgical Approach
- •Abdominal Wall Reconstruction
- •Dealing with a Stoma
- •Follow-up
- •Postoperative Management
- •Management of Postoperative Complications
- •Wound Infection
- •Bleeding
- •Anastomotic Leakage and Recurrent Enterocutaneous Fistula
- •Who to Operate on?
- •Summary Pearls
- •References
- •8: Enteroatmospheric Fistula
- •Introduction
- •History: The Evolving Concept of EAF
- •Prevention
- •Problem: The Fascia Won’t Close Initially, Now What?
- •An Ounce of Prevention
- •Problem: So You Have an EAF (The Early Phase)
- •Diagnosis
- •Control of Sepsis and Resuscitation
- •Early Nutrition
- •Intermediate Phase
- •Nutrition
- •Pharmacologic Therapy
- •Psychiatric Implications of EAF
- •Late/Chronic Phase
- •Timing of Surgery
- •Optimization: Preparation for Surgery
- •Staged vs. Non-staged Approaches
- •Abdominal Wall Reconstruction (AWR)
- •Biologic or Synthetic Mesh
- •Summary Pearls
- •References
- •9: Technical Tips for Difficult Stomas
- •Introduction
- •Preoperative Assessment
- •Prevention of Parastomal Hernias
- •End Ostomy Creation
- •Loop Ileostomy Creation
- •End-Loop Stomas
- •Laparoscopic Ostomy Creation
- •The Obese Patient
- •The Distended Colon
- •The Compromised Stoma
- •Summary Pearls
- •References
- •10: Continent Ileostomy
- •The Continent Ileostomy: Complications, Their Management, and Its Place in the Future
- •The Kock Pouch
- •Formation of the Ileal Pouch
- •Formation of the Nipple Valve
- •Complications and Their Management
- •Early Complications
- •Late Complications
- •Management of Complications
- •Early Complications
- •Late Complications
- •Sliding of the Nipple Valve and Its Correction
- •Prolapse of Nipple Valve
- •Parastomal Hernia
- •Fistula Through the Nipple Valve
- •Miscellaneous
- •Recurrent Nipple Valve Complications
- •Ileitis (Pouchitis)
- •Epithelial Dysplasia and Cancer Risk
- •Ileal Pouch Adenomas in Patients Operated for with Familial Adenomatous Polyposis (FAP)
- •Pouch Removal
- •Criteria of Selection
- •Concluding Remarks
- •The Continent Ileostomy: Its Place in the Future
- •Summary Pearls
- •References
- •11: Rectal Prolapse: Current Evaluation, Management, and Treatment of a Historically Recurring Disorder
- •Etiology and Epidemiology of Prolapse
- •Diagnosis and Evaluation
- •Types of Operative Repair
- •Perineal Operations
- •Abdominal Operations
- •Laparoscopy and Rectal Prolapse Repair
- •Recurrence After Initial Repair
- •Recurrence After Altemeier Procedure
- •Recurrence After Abdominal Approach
- •Types of Operations for Recurrence
- •Our Treatment Preferences for Rectal Prolapse
- •Initial Rectal Prolapse
- •Perineal Proctosigmoidectomy
- •Incarcerated Rectal Prolapse
- •Concomitant Pelvic Prolapse
- •Recurrent Rectal Prolapse
- •Summary Pearls
- •References
- •12: Obstructive Defecation
- •Evaluation
- •History
- •Physical Examination
- •Endoscopy
- •Adjunctive Tests
- •Colonic Transit Study
- •Balloon Expulsion
- •Anorectal Manometry
- •Electromyography (EMG)
- •Imaging
- •Defecography
- •Perineal Ultrasound
- •Our Recommendations
- •Etiology and Treatment Options
- •Non-relaxing Puborectalis
- •Failure of Initial Management/Surgical Options
- •Our Recommendations
- •Rectoceles
- •Surgical Indications
- •Our Recommendations
- •Internal Intussusception
- •Surgical Treatment
- •Our Recommendations
- •Enterocele
- •Surgical Treatment
- •Our Recommendations
- •Sigmoidocele
- •Solitary Rectal Ulcer Syndrome (SRUS)
- •Our Recommendations
- •Persistent Symptoms
- •Sacral Nerve Stimulation
- •Summary Pearls
- •References
- •13: Fecal Incontinence
- •Evaluation
- •History
- •Physical Examination
- •Testing
- •Treatment Options
- •Conservative Management
- •Other Therapies
- •Physical Retraining (Biofeedback)
- •Anal Plug
- •Radiofrequency Energy (RFE)
- •Injectables
- •Sphincter Repair
- •Sacral Nerve Stimulation (SNS)
- •Controversies in Fecal Incontinence Management
- •Repeat Overlapping Sphincter Repair
- •Managing Expectations of Outcome
- •Is a Stoma Ever the Best Option?
- •Defects in the Internal Sphincter Only or Other Types of Lateral Sphincter Defects
- •How to Manage Concomitant Pelvic Floor Disorders (i.e., Rectal Prolapse, Rectocele) if Repairing the Sphincter
- •Future Treatments
- •Magnetic Ring
- •Anal Sling
- •Posterior Tibial Stimulation
- •Summary Pearls
- •References
- •14: Local Treatment of Rectal Cancer (TEM Versus TAMIS Versus Transanal Excision)
- •Introduction
- •Patient Selection
- •Staging the Lesion
- •Why Do Lesions Recur After Local Excision?
- •Location
- •Impact of Lymph Nodes
- •So Whom Should You Select for a Transanal Approach (for Cure)?
- •Operative Approaches
- •“Traditional” Local Excision
- •Minimally Invasive Options
- •Transanal Endoscopic Microsurgery (TEM)
- •Transanal Minimally Invasive Surgery (TAMIS)
- •The Role of Radiation Therapy
- •Summary Pearls
- •Take-Home Points
- •References
- •15: Recurrent Rectal Cancer
- •Introduction
- •Presentation
- •Preoperative Evaluation and Staging
- •Preoperative Planning
- •Physical Examination
- •Carcinoembryonic Antigen
- •Radiologic Imaging
- •Local Disease
- •Computed Tomography (CT)
- •Magnetic Resonance Imaging (MRI)
- •FDG-PET
- •Distant Disease
- •Imaging Summary Recommendations
- •Histology
- •Multimodal Therapy
- •Role of Neoadjuvant Therapy
- •Intraoperative Radiation Therapy (IORT)
- •Surgical Technique
- •Preoperative Regimen
- •Rectal Washout
- •Resection
- •Types of Procedures
- •Sacral Resections
- •Pelvic Floor Reconstruction
- •Postoperative Complications
- •Stoma
- •Oncologic Outcomes of Multimodal Therapy
- •Palliative Management
- •Radiation
- •Self-expanding Metallic Stents (SEMS)
- •Surgery: Fecal Diversion vs. Palliative Resection
- •Multidisciplinary Approach
- •Centers of Excellence
- •Summary Pearls
- •References
- •16: The Approach to the Rectal Cancer Patient with a Suspected Complete Clinical Response: Selection of Patients to the Watch and Wait Strategy
- •Introduction
- •Indications for Neoadjuvant Therapy
- •Types of Neoadjuvant Therapy
- •Assessing Tumor Response: Why?
- •Assessing Tumor Response: When and How?
- •Local Excision of the Tumor Site
- •Radiological Imaging
- •Carcinoembryonic Antigen (CEA)
- •Summary Pearls: Final Decision Management
- •Additional Therapy
- •References
- •17: Ileal Pouch Complications
- •Introduction
- •Factors Associated with Pouch Failure
- •Pelvis Sepsis
- •Evaluation of Pouch Dysfunction
- •MRI Pelvis
- •CT Enterography
- •Tests of Anorectal Physiology
- •Surgical Decision-Making
- •Intraoperative Challenges During Ileoanal Pouch Creation and Anastomosis
- •Problems with Reach of the Pouch
- •Ischemia of the Pouch
- •Problems with Stoma Creation
- •Management of Surgical Complications Related to the Pouch
- •Early Complications
- •Anastomotic Disruption and Pelvic Abscess
- •Postoperative Bleeding from the Pouch
- •Late Complications
- •Pouch-Vaginal Fistula (PVF)
- •Investigations
- •Treatment Options for PVF
- •Local Procedures
- •Advancement Flap Repair
- •Fibrin Glue, Fistula Plug, Biologic Mesh Repair, and Gracilis Muscle Interposition
- •Failure of Flap Repair
- •Perineal Pouch Advancement
- •Redo IPAA
- •Loop Ileostomy
- •Pouch-Perineal Fistula (PPF)
- •Pouch Sinus
- •Crohn’s Disease of the Pouch
- •Incontinence
- •Outlet Dysfunction
- •Pouch Prolapse
- •Leak from the Tip of the “J”
- •J-Pouch to K-Pouch (Continent Ileostomy) Conversion
- •Pouch Failure: Permanent Diversion with Pouch In Situ or Pouch Excision?
- •Cancer of the Pouch
- •Redo Pouch Surgery
- •Operative Technique
- •Summary Pearls
- •References
- •18: The Failed Anastomosis
- •The Healing Anastomosis
- •The Anatomical Perspective
- •Mucosa
- •Submucosa
- •Muscularis Propria
- •Serosa
- •The Physiologic Perspective
- •Proliferative Phase
- •Remodeling
- •Failed Anastomotic Healing
- •Tissue Perfusion
- •Macrovascular Anatomy
- •Sudeck’s Point
- •Rectal Stump
- •Microvascular Anatomy
- •Arterial Oxygen Tension
- •Summary Pearl
- •Risk Factors
- •Patient-Related
- •Poor Nutritional Status
- •Immunosuppression
- •Steroids
- •Crohn’s Disease
- •Radiation
- •Diverticulitis and Emergency Surgery
- •Peritonitis
- •“Loaded Colon”
- •Hemodynamic Instability
- •Location
- •Obesity and Male Gender
- •Operative Risk Factors
- •Blood Loss, Transfusions, and Operative Time
- •Intraoperative Complications
- •Total Mesorectal Excision (TME)
- •Tension and Splenic Flexure Mobilization
- •Drains
- •Laparoscopy
- •Omental Wrapping
- •Simultaneous Liver Resection
- •Proximal Diversion
- •Mechanical Bowel Preparation (MBP)
- •Prevention
- •Intraoperative Anastomotic Assessment
- •Laser Fluorescence Angiography
- •Intraoperative Air Leak Test
- •Intraoperative Endoscopic Assessment
- •Intraoperative Dye Test
- •Intraluminal Devices
- •Transanal Decompression Devices
- •Intraluminal Barriers
- •Compression Anastomosis
- •Extraluminal Devices
- •Managing the Failed Anastomosis
- •Anastomotic Leaks
- •Clinical Manifestations
- •Making a Timely Diagnosis
- •Determining the Appropriate Intervention
- •Symptomatic Versus Asymptomatic
- •Postoperative Sepsis
- •Presence of Diverting Ostomy
- •Diversion, Resection, and Revision
- •Suture Repair
- •Management Unique to the Crohn’s Patient
- •Management After the Acute Setting
- •Endoscopic Vacuum-Assisted Closure (Endoluminal VAC) or Endo-Sponge™
- •Fibrin Glue
- •Covered Stents
- •Transanal Repair
- •Redo Surgery
- •Anastomotic Stenosis
- •Pathophysiology
- •Symptoms and Clinical Course
- •Treatment
- •Balloon Dilation
- •Stents
- •Complete Obstruction
- •Surgical Revision
- •Anastomotic Stenosis Summary
- •References
- •19: Pelvic Bleeding
- •Introduction
- •Risk Factors for Major Bleeding
- •Prevention
- •Controlling Bleeding
- •Summary Pearls
- •References
- •20: Hemorrhoidal Disease: Postoperative Complications
- •The Hemorrhoidal Consult
- •Dietary and Bowel Habits
- •Colonoscopy
- •Antiplatelet Agents and Anticoagulants
- •“Every pain in the bottom is not a hemorrhoid” – How to deal with patients and referring providers when this is not hemorrhoids and they are convinced it is
- •Surgical Decision-Making: How to Decide on What Surgery to Do (Open, Closed, Energy, PPH, THD)
- •Transanal Hemorrhoidal Dearterialization (THD)
- •Hemorrhoidal Crisis: What Do You Decide to Do at the Time?
- •Postoperative Regimen
- •Bowel Management and Avoiding Constipation
- •Pain Control with Narcotics, NSAIDS
- •Sitz Baths: Do They Work?
- •Preoperative Counseling and Postoperative Instructions
- •Banding
- •Stapled Hemorrhoidopexy
- •Excisional Hemorrhoidectomy
- •Complications of Hemorrhoidectomy: What Are They, How Often Do They Occur, and How to Approach and Manage Them?
- •Urinary Retention
- •Hemorrhage
- •Whitehead Deformity
- •Fecal Incontinence
- •Anal Stricture
- •Chronic Open Wounds
- •Wet Anus and Pruritus Ani
- •Chronic Pain
- •Skin Tags (They Want It Flat!)
- •Recurrent Hemorrhoids
- •Banding Complications
- •Pain
- •Bleeding
- •Vasovagal Symptoms and Syncope
- •Sepsis
- •Recurrence
- •Stapled Hemorrhoidopexy (PPH)
- •Indications: When Should We Be Using This Procedure?
- •Chronic Pain
- •Recurrence
- •Sphincter Damage
- •Too Low Stapler Placement: Post-PPH Syndrome
- •Bleeding
- •Preventing Complications
- •Technical Tips: Excisional Hemorrhoidectomy
- •Patient Selection
- •Fluid Restriction (Urinary Retention)
- •Summary Pearls
- •References
- •21: Fistula-in-Ano
- •Background
- •Pathophysiology
- •Evaluation and Workup
- •History
- •Physical Examination
- •Imaging Studies
- •Fistulography
- •CT Scan
- •Endoanal Ultrasound
- •Treatment
- •General Principles
- •Operative Management
- •Lay-Open Technique (Fistulotomy)
- •Setons
- •Anorectal Advancement Flap
- •Fibrin Glue
- •Anal Fistula Plug
- •LIFT Procedure
- •Fistulectomy
- •Dermal Flaps
- •Results
- •My Approach
- •Complications
- •Incontinence
- •Recurrence
- •Special Considerations
- •Extrasphincteric Fistula
- •Crohn’s Disease
- •Fistula-in-Ano in the HIV-Positive Patient
- •Rectourethral Fistulas
- •Summary Pearls
- •References
- •22: Anal Intraepithelial Neoplasia (AIN)/High-Grade Squamous Intraepithelial Lesion (HSIL)
- •Introduction and Controversy
- •Lack of Adoption
- •HSIL and Anal Cancer: The Problem
- •Treatment
- •High-Resolution Anoscopy (HRA): Initial Examination and Technique
- •Dealing with Recurrence
- •Coding
- •Follow-Up
- •Topical Agents
- •Infrared Coagulation
- •Vaccination
- •Special Situations: The HIV (+) Patient
- •Anal Cytology and Screening/ Surveillance Intervals
- •Final Thoughts
- •Summary Pearls
- •References
- •23: Chronic Anal Pain
- •Introduction
- •Acute Anal Pain
- •Thrombosed External Hemorrhoid (Fig. 23.1)
- •Anal Fissure (Fig. 23.3)
- •Anorectal Abscess/Fistula (Fig. 23.4)
- •Acute or Chronic Anal Pain
- •Hidradenitis Suppurativa (Fig. 23.6)
- •Pruritus Ani (Fig. 23.7)
- •Retrorectal Tumors
- •Bicycle Seat Issues
- •Prostatitis
- •Constipation
- •Gynecological Sources
- •Proctitis/Pouchitis
- •Radiation
- •Anorectal Stricture
- •Anal Cancer
- •Foreign Bodies
- •Rectal Prolapse
- •Neurogenic Pain
- •Infectious Causes of Anal Pain (Table 23.2)
- •Gonorrhea
- •Herpes Simplex, Genitalis, and Zoster
- •Syphilis
- •H . ducreyi (Chancroid)
- •Chlamydia (LGV)
- •Chronic Anal Pain
- •Levator Spasm
- •Epidemiology
- •Management
- •Coccygodynia
- •Pudendal Neuralgia
- •Summary Pearls
- •References
- •24: Complex Pilonidal Disease and Acute and Chronic Perineal Wounds: Point – Counterpoint
- •Surgical Management of Complex or Recurrent Pilonidal Sinus
- •Pilonidal Cystectomy Combined with Fasciocutaneous Advancement Flap
- •My Approach (Dr. Orangio)
- •A Case of Recurring Draining Sinuses
- •Healing by Secondary Intention (Dr. Abcarian)
- •My Approach (Dr. Abcarian)
- •Point: Counterpoint
- •Dr. Abcarian and Dr. Orangio
- •Management of the Perineal Wound
- •Disease Process
- •Low Rectal Cancer and Anal Canal Cancer
- •Management of the Nonhealing Chronic Perineal Wounds
- •Disease Process
- •Nonoperative Treatment
- •Operative Management
- •Summary Pearls
- •References
- •26: The Morbidly Obese Patient
- •Introduction
- •Abdominal Obesity: Not All Obesity Is the Same
- •Preoperative Evaluation
- •Systems-Based Evaluation and Prevention Tips
- •Laparoscopic Colectomy in the Obese Patient
- •Lesion Localization
- •The Value of Your Assistant
- •Patient Setup, Port Placement, and Exposure
- •Dissection Techniques
- •Specimen Extraction and Ideal Wound Placement
- •The Role of Hand-Assisted Laparoscopic Colectomy in the Obese Patient
- •Technical Considerations
- •Pelvic Dissection
- •Ileal Pouch-Anal Anastomosis (IPAA) in the Obese Patient
- •Rectal Cancer in the Obese Patient
- •Anorectal Surgery in the Obese Patient
- •Anorectal Fistulas
- •Sphincteroplasty
- •Hemorrhoidectomy
- •Summary Pearls
- •References
- •27: The Pediatric Patient
- •Introduction
- •Anorectal Disease
- •Perianal Abscess and Fistula-in-Ano
- •Hemorrhoids
- •Anal Fissure
- •Rectal Prolapse
- •Constipation
- •Evaluation
- •Treatment
- •Surgery: Sphincter Procedures, Antegrade Continence Enema, and Stoma
- •Incontinence
- •Functional Non-retentive Fecal Soiling
- •Anorectal Malformations
- •Spinal Pathology
- •Sphincter Damage
- •Anorectal Crohn’s Disease
- •Crohn’s Colitis
- •Ileocolic Crohn’s Disease
- •Chronic Ulcerative Colitis
- •Ulcerative Colitis Emergencies
- •Polyposis Syndromes
- •Summary Pearls
- •Examination
- •Preoperatively and Intraoperatively
- •Postoperatively
- •Conclusion
- •References
- •28: Functional Problems Following Colorectal Surgery
- •Introduction
- •Scope of the Problem
- •Colectomy
- •Proctectomy
- •Rectal Cancer
- •Ulcerative Colitis and Familial Cancer Syndromes
- •Anorectal Procedures
- •Prolapse Surgery
- •Management
- •Diarrhea
- •Fecal Incontinence
- •Constipation/Obstructed Defecation
- •Summary Pearls
- •References
- •29: Short Bowel Syndrome
- •Introduction
- •Pathophysiology
- •Small Intestinal Resection
- •Loss of the Ileocecal Valve
- •Loss of the Colon
- •Crohn’s Disease
- •Mesenteric Ischemia
- •Radiation Enteritis
- •Clinical Manifestations
- •Diagnosis and Assessment
- •Medical Management
- •Parenteral Nutrition
- •Complications Associated with Long-Term Parenteral Nutrition
- •Enteral Nutrition and Oral Diet
- •Pharmacologic Agents
- •Growth Factors
- •Surgical Management
- •Restoration of Intestinal Continuity
- •Procedures to Slow Intestinal Transit
- •Procedures to Lengthen Residual Bowel
- •Other Non-transplant Procedures
- •Small Bowel Transplantation
- •Future Directions
- •Outcomes
- •Summary Pearls
- •References
- •30: The Intraoperative Consult
- •Initial Mindset
- •Initial Evaluation
- •Positioning
- •Initial Survey
- •Examination
- •Exposure/Operative Procedure
- •Common Intraoperative Consults
- •Extensive Adhesions
- •Injury to Large or Small Bowel
- •Injury to Rectum
- •Mass
- •Cancer and Polyps
- •Endometriosis
- •Meckel’s Diverticulum
- •Presacral Bleeding
- •Ischemic Bowel
- •Vaginal Delivery Complications
- •Endoscopic Complications
- •Intraoperative Conditions
- •Laparoscopic Approach Desired
- •Not Marked for a Stoma
- •Damage Control: How Do You Bail?
- •Communication with Family
- •Legal Issues and Documentation
- •Summary Pearls
- •References
- •31: Laparoscopic Complications
- •Introduction
- •Tips to Avoiding Complications at the Beginning
- •Positioning
- •Dealing with the Small Bowel
- •Trocar- and Instrument-Related Injuries
- •Unique Complications: Right Colectomy
- •Exposure
- •Identifying the Correct Dissection Plane
- •Identifying/Handling the Duodenum
- •Major Vascular Pedicle Ligation
- •The Right Ureter
- •Unique Complication: Sigmoidectomy
- •Exposure/Mobilization of the Left Kidney
- •Identifying the Ureter
- •Splenic Flexure
- •Redo Operation and Conversion
- •Summary Pearls
- •References
- •32: Laparoscopy, Robotics, and Endoscopy
- •Laparoscopy: Introducing Technology in Colorectal Surgery
- •Hand-Assisted Laparoscopic Surgery (HALS)
- •Future Direction: Robotic Technology
- •Single-Incision Laparoscopy Surgery
- •Evolving Endoscopic Techniques
- •Endoscopic Mucosal Resection (EMR)
- •Endoscopic Submucosal Dissection (ESD)
- •Combining Laparoscopy and Endoscopy
- •The Cost of New Technology
- •Summary Pearls, Patient Selection, and Personal Preferences
- •Conclusion
- •References
- •33: Technical Aspects
- •Introduction
- •Intestinal Anastomosis
- •Stapled Versus Hand Sewn and Single Versus Double Layer

492
ab
D.S. Keller and C.P. Delaney
Fig. 32.3 Cosmetic comparison for total colectomy through ( a ) SILS and ( b ) traditional laparoscopic approach
Another reported advantage of a single incision is less postoperative pain than conventional LC [ 87 , 90 ]. The reduction in
pain translated to lower total narcotic use was in the immediate postoperative period, with lower pain scores reported up
learning curve and refi nement of the SILS technology.
Robotic- utilizing surgeons feel that robotics may also reduce
the negativities of SILS such as loss of triangulation and
poor visualization and further advance the technology.
to postoperative day 2. SILS has also shown a signifi cantly
shorter length of stay (LOS); studies have demonstrated LOS
more than 1 day shorter for SILS compared to multi-post-lap-
Evolving Endoscopic Techniques
aroscopy (Table 32.2 ) [ 81 , 87 ].
Despite the benefi ts, some issues exist with SILS. The
Endoscopic Mucosal Resection (EMR)
proximity of the trocars at a fi xed position, restricted freedom of the hands, and clashing of the instruments is some-
what contradictory to the traditional teaching of instrument
triangulation in laparoscopy [ 91 ]. The problems in exposure
and the risk of “ crowding ” while maneuvering laparoscopic
instruments add to the diffi culty in the SILS technique [ 92 ]
(Video 32.3 , Courtesy of Virgilio George, MD). An additional learning curve is involved for the technique, extra incisions are sometimes required [ 82 , 93 ], and there is a minor
increase in cost over laparoscopic surgery [ 84 , 94 ]. SILS
may also make teaching more diffi cult. Previous studies have
demonstrated unique requirements of SILS, with skill sets
and ergonomic demands which cannot be directly adapted
from existing LAP experience [ 95 ]. Thus, the implementa-
tion of an evidence- and competency-based SILS curriculum
is necessary to ensure appropriate training of future SILS
surgeons. Currently, resident training modes are in development for SILS, and the attending may be performing more of
the case, at the expense of resident education. Many of these
issues can be improved with operator ascension up the
Key Concept : EMR provides en bloc or piecemeal removal of
premalignant and early colorectal lesions typically < 20 mm
that may have otherwise required resection .
Advanced endoscopic technology has been introduced to
allow for treatment of colorectal tumors without the morbidity of a surgical resection. These endoscopic techniques have
permitted more aggressive and successful polypectomy,
including en bloc removal of otherwise unresectable lesions
[ 96 ]. Endoscopic mucosal resection (EMR) is an option for
endoscopic polypectomy of colorectal polyps without stalks.
EMR differs from standard snare polypectomy by the use of
submucosal solution injection, which allows for the complete resection of the mucosa through the mid to deep submucosa [
97 ]. EMR is useful for the removal of adenomas
that are too large for standard snare polypectomy and essentially allows removal of colonic lesions in a minimally invasive way that would otherwise require surgical colectomy
(see Video
25.1 ) [ 98 ]. Although not an absolute contraindi-
cation, it is typically more diffi cult to remove tumors >20 mm

32 Laparoscopy, Robotics, and Endoscopy
493
Table 32.2 Published
reports of single-incision
colectomy
Mean OR time
Author Year Patients BMI
Buche r [ 80 ] 2008 1 N/A 158 N/A 3 1/0
79 ] 2008 1 35 115 4 3.5 1/0
Remzi [
Rieger 2009 7 24.3 89 5.4 3.1 6/1
Geisler 2009 1 24 172 4 2 TPC
Merchant [
Remzi 2009 1 25.8 198 3 3 0/1
Law 2009 1 N/A 180 3 3 0/1
Chambers [
Leroy 2009 1 21 90 4 2 0/1
Bucher 2010 1 22 125 2 2 0/1
Adair [
Gandhi 2010 24 28.5 143 2.7 3.8 19/5
Papaconstantinou [
Chen [
Fichera 2011 10 21.9 139 5.1 – TPC
McNally 2011 27 27 114 3 – 14/8
Wu 2011 27 – 180 7 4.1 8/18
Ross 2011 39 25.6 120 4.4 4.2 30/9
Ramos-Valadez 2012 20 27.7 159.2 3.2 3.3 0/20
Walters 2012 100 26 105 4 100/0
N / A n ot available, TPC total proctocolectomy, BMI body mass index, R right-sided surgery, L left-sided surgery, LOS
length of stay, min minutes, d days
a
Concomitant cholecystectomy
b
In addition: 2 TPC and 1 abdominal colectomy with ileorectal anastomosis
c
In addition, 5 SILS transverse colectomies
d
In addition, 1 TPC
91 ] 2009 1 N/A N/A 3 2.5 1/0
88 ] 2009 6 N/A 82 1.9 2.5 b 2/1
83 ] 2010 17 26.2 139 5 3 17/0
81 ] 2011 29 30 128.8 3.4 4.9 29/0
85 ] 2011 18 23.3 175 5 4 18/0
(min) LOS (d)
a
N/A 2 0/1
Incision length
(cm) R/L
c
d
by en bloc resection using EMR, with reported success rates
of ~30 %; thus, decisions should be made on an individual
basis [ 99 – 101 ]. Piecemeal excision (while limiting the full
extent of fi nal pathological analysis) can also be used to
facilitate removal of larger lesions to a large extent in experienced hands [ 102 ].
To perform EMR, the lesion is oriented to maximize the
infl uence of gravity, then a submucosal injection creates a
fl uid “cushion” between the mucosa and muscularis propria
to elevate the lesion into the lumen. Following the injection
lift, a snare is deployed to fully remove the lesion with a
2–3 mm margin of normal mucosa [ 102 ]. Because the plane
of resection during EMR is typically the middle to deep submucosal layer, compared with standard polypectomy, which
normally provides resection at a mucosal level, EMR offers
the advantage of providing en bloc resection specimens.
Outcomes for EMR are very good for experienced providers. A meta-analysis and systematic review of successful
en bloc resections of large colorectal polyps by EMR found
complete cure rates improved from 44.19 to 69.17 %, concluding EMR is an effective technique and offers an alternative to surgery [
103 ]. An Australian study of EMR in 174
patients with diffi cult polyps reported a 95 % procedural
success, 90 % avoided the need for surgery, no perforations,
and signifi cant cost savings compared to surgical resection
104 ]. The most frequently reported major complications –
[
perforation (0–5 %) and bleeding (0.5–6 %) – may require
surgical management, and removal of large sessile lesions is
technically demanding, often requiring a lengthy procedure
time to retrieve fragments of lesions and may require multiple endoscopic sessions for complete ablation of a large
adenoma [ 98 ].
Endoscopic Submucosal Dissection (ESD)
Key Concept : ESD provides an improved ability for en bloc
resection over EMR and is a better option for larger superfi cial colorectal tumors ; however , it is technically demanding
and has a higher rate of complications .
Endoscopic submucosal dissection (ESD) was developed
to overcome the limitations of conventional EMR. ESD
is primarily used in Japan and in select centers in Europe
and the USA to resect larger polyps and selected invasive
tumors and aid in achieving higher rates of en bloc resection of superfi cial tumors than EMR. ESD is a complicated
technique for treating large superfi cial colorectal tumors
because it provides a higher en bloc resection rate and is less

494
D.S. Keller and C.P. Delaney
invasive than surgical resection. Others have proposed that
this technique is suitable for all large polyps, early colorectal
cancer, and those lesions that cannot be accessed by transanal
or TEMS routes and wish to avoid major resection. ESD can
be considered in lesions that have a higher rate of submucosal infi ltration and require detailed histopathologic diagnosis
by en bloc resection or when fi brosis has developed on the
submucosal layer from biopsy and EMR is diffi cult because
of non-lifting signs [
105 ].
The technique of ESD involves an endoscope with a single
channel, along with a high-frequency generator (Video 32.4 ,
Courtesy of Peter Marcello, MD). After identifi cation of a
lesion, a mixture of 1 % hyaluronic acid solution and 10 %
glycerin solution is injected around the lesions to elevate the
submucosa [ 106 ]. The border of the tumor is initially marked
by indigo carmine dye with 1 cm margins. Following a mucosal incision, a partial or circumferential incision is made with
injection of hyaluronic acid solution into the submucosa, and
the dissection is carried down to the deep submucosa. This
process is continued around the tumor until the entire lesion
is resected en bloc [ 107 ]. The en bloc excision with ESD has
a number of theoretical advantages, including more accurate
histologic assessment, reduced recurrence, decreased endoscopic surveillance requirements, and potential surveillance
cost savings [ 102 ]. For laterally spreading rectal tumors,
ESD is becoming more prevalent, although transanal endoscopic microsurgery is still frequently used [ 108 ]. ESD also
has the additional advantages of minimal invasiveness and
avoidance of anesthesia [ 109 ]. Successful en bloc resection
has been reported in up to 85–89 % of cases, with piecemeal
resection in the remaining 10–15 % [ 100 , 105 , 110 – 112 ].
However, there are risks with this new technology. ESD
is still associated with higher perforation rate, longer procedure times, and increased technical diffi culty [ 113 ]. The
thinner colorectal wall and winding nature of the colon make
colorectal ESD an especially diffi cult operative technique
[ 114 ]. Further, residual disease has been reported in 2–3 %
with ESD [
115 ]. The application of colorectal ESD needs
to be further evaluated, with improvements in technology in
the technical skill, and surgical devices are required before
widespread use.
Endoscopic techniques have evolved to the point where they
can be applied to full-thickness resection of polyps, reducing
risk compared to surgical resection and accelerating patient
recovery. The Tissue Apposition System ( TAS ) was developed
to facilitate this approach (Video 32.5 ). TAS is a novel endoscopic suturing system that enables endoluminal full-thickness
closure [
96 ]. The polypectomy site is closed under laparo-
scopic observation to avoid injury to surrounding structures.
In a feasibility study, TAS was demonstrated to be safe under
laparoscopic guidance [ 96 ]. Initial studies have shown no long-
term complications and normal healed mucosa with the sutures
and anchoring devices in place at follow-up colonoscopy
116 ]. TAS may increase the number of patients whose diffi cult
[
polyps can be removed endoscopically, avoiding the need for
a surgical resection in select patients. Based on early results,
TAS sets the future direction in minimizing surgery for endoscopically unresectable colonic polyps. These endoscopic
technological advances are improving lesion assessment and
standardization, and new methods and techniques are being
developed to enhance procedural safety and effi cacy.
Combining Laparoscopy and Endoscopy
Key Concept : Combining colonoscopy with laparoscopy
allows removal of select previously inaccessible polyps without the morbidity of a surgical resection . Additionally , a
standard resection can be performed at that time given
advanced pathology , technical problems , or an inability to
perform endoscopic removal .
Adding the laparoscopic approach to endoscopically
unresectable polyps enriches the therapeutic spectrum. Due
to location or size, some polyps are deemed unsafe or technically impossible to treat endoscopically and require colectomy. The perceived risk of iatrogenic injury including
hemorrhage and colonic perforation may prevent an attempt
at polypectomy [ 117 ]. In such cases, where standard polypec-
tomy via the colonoscope is considered not technically possible, patients may be referred for colonic resection. However,
there is signifi cant morbidity associated with a surgical resection, including wound infection, anastomotic leak, ileus,
and death [ 3 , 5 , 10 , 18 , 118 ]. By combining laparoscopic
mobilization of the bowel with colonoscopic polypectomy
– combined laparoscopic and endoscopic resection ( CLER )
– previously inaccessible polyps could be snared, and laparotomy with enterotomy or bowel resection can be avoided
(Fig. 32.4 ; Video 32.6 ). Franklin et al. reported on a series
of 110 patients undergoing colonoscopic polypectomy following laparoscopic mobilization of the colon [ 119 ]. Smaller
studies have also demonstrated the feasibility of CLER technique for small series of unresectable polyps [ 120 – 124 ]. A
10-year review of CLER for noninvasive or benign colorectal polyps found low rates of conversion (5 %), major postoperative complications, and intraoperative complications
(1 %). However, follow-up colonoscopy revealed metachronous adenomas in more than one-third of patients [ 125 ].
The authors concluded that CLER is an effi cient, safe, and
minimally invasive alternative to open resection for selected
patients with diffi cult polyps. Further experience and results
of large-scale trials are needed before applying CLER more
broadly. Above all, it is imperative to have the polyp assessed
by an experienced endoscopist before embarking on a CLER
as this may save the patient from undergoing general anesthesia. The majority of polyps are still possible to remove by
standard endoscopic techniques.

32 Laparoscopy, Robotics, and Endoscopy
Fig. 32.4 Combined laparoscopic and endoscopic resection
procedure
495
The Cost of New Technology
Key Concept: There is a balance on the cost of acquisition ,
learning , and maintenance of new technology with the poten-
tial benefi ts that each surgeon must consider .
It is increasingly necessary to consider the cost of new
technology with the need for the new innovations, especially given the ongoing health-care crisis in the USA. It
is well known that health-care costs are rising at an unsustainable rate, as evidenced by expenditures in the USA
nearing $2.6 trillion in 2010, over ten times the $256 billion spent in 1980 [ 126 ]. Projections show that this trend
is continuing, with National Health Expenditures doubling
from 2.6 to 5.2 trillion and accounting for 20 % of the
gross domestic product by 2020 [ 127 ]. In an era of increas-
ing health-care costs, decreasing reimbursements, and low
operating margins, cost-effi ciency will become an essential
for fi nancial survival for patients, employers, providers, and
payers alike. Surgical interventions are a prime target for
cost- effectiveness, as they are associated with signifi cant
equipment costs and increased costs and lower reimbursement associated with complications. If there is a measurable
patient benefi t and the possibility to become more effi cient
with the technology (either through experience or direct
equipment costs), the benefi ts will eventually outweigh the
costs. Laparoscopic colorectal surgery is the ideal model
when considering balancing costs versus technology. LC has
evolved into a cost-effective technology. Compared to OC,
the laparoscopic method is associated with higher operating
room costs [ 128 – 131 ]; however, the initial higher operating
room and equipment cost is generally offset by shorter LOS
and improvements in patient quality of life [ 6 , 7 , 11 , 128 ,
130 , 132 , 133 ]. Moreover, laparoscopy has facilitated the
application of enhanced recovery pathways in colorectal
surgery [ 134 , 135 ], along with their associated improved
resource utilization [ 11 , 136 ]. These potential benefi ts may
outweigh the increased costs at the time of surgery. As LC
has increased in use and effi ciency, cost improvements and
lower overall direct costs have resulted [ 7 , 136 ]. While cost
effi ciencies had been less clear for LRR, a recent model
reported a cost-benefi t of $4,283 for both laparoscopic
colon and rectal cancer resections [ 137 ].
One of the major concerns about robotic surgery is its
cost. Those in favor of robotics emphasize that robotics is
a technology that is still relatively new. Whereas much of
the reported early experience of laparoscopy demonstrated
higher costs when compared to open, that has changed over
time. Furthermore, despite the cost-effi ciency of laparoscopy in colon resections, a recent 2009 Inpatient Sample
shows that only 35 % of colectomies performed in the USA
were done laparoscopically [ 138 ]. In cases where the dif-
fi culty of performing laparoscopic surgery prevents its use,
robotic technology is another minimally invasive option.
The reduction in conversion to open rates that may be provided through robotics may justify its cost, although a 5 %
reduction in conversion rate, then the additional cost per conversion saved would equal 20 times the additional cost of
a single robotic case – generally estimated as about $2,500
per case in most series. Currently, the increase in cost for
robotics ranges from acquisition, maintenance, and operative

496
D.S. Keller and C.P. Delaney
time [ 46 , 49 , 60 , 69 , 72 ]. These additional costs are borne
by the health-care facility, without any increase in reimbursement or incremental advantage related to reduction in
length of stay or reduced complications, benefi ts that made
LC cost-effective when compared with open surgery [
The fi nancial feasibility of robotic colorectal surgery may
require incremental admission volume for other diagnoses
due to reduced length of stay [ 139 ], a reduction in the cost
of robot acquisition and reusable equipment, or increased
competition from manufacturers and wider dissemination
of the technology [ 50 ]. The best practice for cost- effi ciency
may be to concentrate robotic colorectal surgery at selected
high-volume centers while it undergoes further evaluation,
thereby trying to optimize effi ciency and quality.
With laparoscopy now proving to be cost-effective in its
maturity and the cost analysis of robotics currently being
evaluated, we must keep in mind these arguments apply also
for the other emerging technologies such as SILS, CLER,
ESD, and EMR. On the upside, SILS improves cosmesis and
has reported other advantages. On the downside, SILS technology utilizes new single-port access devices and can
potentially increase operative times, cost, and make learning
curves more complicated for trainees. In addition, while
ESD and EMR may avoid a formal resection, patients undergoing ESD and EMR have an increased need for multiple
follow-up colonoscopies, which can increase health-care
costs as well. Emerging technologies give modern medicine
an exciting opportunity to improve patient outcomes but can
increase cost – especially direct costs. By integrating costeffective technology into practice, we have the opportunity
to improve both patient and fi nancial outcomes.
71 ].
Summary Pearls, Patient Selection, and Personal Preferences
Key Concept : While the concept of new technology is exciting , careful consideration of the patient and their pathology
is necessary to choose the appropriate technology . Each surgeon must develop their own preferences for new technology
based on their training and personal experience .
Careful planning is needed to decide when to use ESD or
EMR versus CLER or a formal resection. En bloc excision
using EMR is limited to lesions 20 mm or smaller, with minimal invasion to the submucosa, more than one-third of the
luminal diameter, and no invasion to lymphatic channels or
vessels. As it is diffi cult to perform en bloc EMR resection
for lesions larger than 20 mm, piecemeal EMR becomes the
least invasive and least costly option for these lesions [ 102 ].
In our hands, ESD is reserved for polyps that fail EMR, or
are not suitable for EMR because of scarring or location.
Based on polyp anatomy and location, a decision is then
made to perform ESD or CLER. This is done in the operating
room, so that if during intraoperative endoscopy a decision is
made that the polyp cannot be removed, a laparoscopic colectomy is performed at the same time. We have not used
ESD for cancers and prefer to perform a laparoscopic segmental colectomy in those cases, as our morbidity rates are
136 ]. The inability to raise the base of a polyp after
low [
submucosal injection can indicate the presence of cancer
invading deep into the submucosa and that patient should be
referred for surgical resection [
predict depth of invasion helps to decide whether to pursue
EMR, ESD, or formal resection remains somewhat diffi cult.
Pre-procedure staging with endoscopic ultrasound (EUS)
can serve as a useful tool by determining the depth of invasion and by detecting the presence of lymph nodes that may
indicate malignancy and ability to perform (or not perform)
an endoscopic resection.
Personal and patient factors infl uence the use of SILS.
Since studies published by Drs. Champagne and Delaney
showed no signifi cant improvement over standard laparoscopy [ 84 ], Dr. Delaney uses SILS in a selected fashion and
primarily to educate residents. In contrast, many surgeons
are proponents of SILS – they and their patients appreciate
the improved cosmesis and reduction in postoperative pain.
Surgeons that endorse SILS tend to use both laparoscopic
and robotic SILS in their practice, fi nding SILS to be easier
with the robot.
The application and indications for CLER are still under
development. Dr. Delaney does not often use CLER. If the
gastroenterologist performing the colonoscopy feels he or
she can get to a lesion endoscopically with help, Dr. Delaney
will use a CLER approach. Otherwise, if a lesion is not amenable to endoscopic polypectomy, he offers a formal resection; the option of CLER is discussed but only performed if
the patient insists. In his experience, a large percentage of
these unresectable lesions are invasive cancer, and a formal
colectomy is needed anyway. Further, the morbidity of a segmental colectomy is favorable versus attempting CLER. Dr.
Delaney performs EMR preferentially for all cases, including rectal polyps, saving patients the anesthesia required for
ESD, CLER, or resection. In 30–50 % of cases referred by
outside gastroenterologists for resection, he removes the polyps endoscopically.
The use of robotics is a hotly debated topic. Dr. Delaney
does not use robotics since the initial paper he published in
2003 [ 70 ], as well as a series of patients he did since that
time. In his opinion, the cost of this technology is not justifi ed for abdominal or rectal resections, and there is no
tangible benefi t realized over traditional laparoscopy. In
an opposing view, other surgeons are strong supporters of
robotics. They fi nd it offers improved surgeon ergonomics
and a superior approach in pelvic dissections, SILS, and high
BMI patients that would not be possible with traditional laparoscopy. These surgeons consider that robotics is a natural
140 ]. Having the ability to

32 Laparoscopy, Robotics, and Endoscopy
497
evolution of minimally invasive surgery and that the technology will be more widely accepted when there is more robotic
competition and choices. This increased market competition
will hopefully drive the cost of robotic technology down, as
it did in laparoscopy.
Conclusion
The future of technology in colorectal surgery is exciting.
New technology innovation in health care is an important
driver of growth. With the current state of health care, it
behooves us to strategically incorporate new innovations to
streamline the delivery of quality health care and optimize
patient outcomes. Successful integration of technology
requires patience along the learning curve and careful patient
selection to match the appropriate technology to the patient
and disease process. Using the integration of laparoscopy as
a model, the benefi ts have the potential to outweigh early
technical diffi culties and ineffi ciencies. Incorporating new
technology will facilitate meeting meaningful use requirements and connecting with physicians, payers, and the community. Furthermore, wisely investing in new technology
allows measuring incremental improvement in clinical outcomes for patients and use of health-care resources.
References
1. Akle CA. Early parietal recurrence of adenocarcinoma of the colon
after laparoscopic colectomy. Port site metastasis after laparoscopic
colorectal surgery for cure of malignancy. Br J Surg. 1996;83(3):427.
2. Jenkins NL, Roth JS, Johnson JO, Pofahl WE. Laparoscopic colorectal
surgery: indications and techniques. Curr Surg. 2005;62(3):319–23.
3. Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350(20):2050–9.
4. Bonjer HJ, Hop WC, Nelson H, Sargent DJ, Lacy AM, Castells A,
et al. Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Arch Surg. 2007;142(3):298–303.
5. Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P,
Pique JM, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised
trial. Lancet. 2002;359(9325):2224–9.
6. Schwenk W, Haase O, Neudecker J, Muller JM. Short term benefi ts
for laparoscopic colorectal resection. Cochrane Database Syst Rev.
2005;(3):CD003145.
7. Delaney CP, Kiran RP, Senagore AJ, Brady K, Fazio VW. Casematched comparison of clinical and fi nancial outcome after laparoscopic or open colorectal surgery. Ann Surg. 2003;238(1):67–72.
8. Delaney CP, Marcello PW, Sonoda T, Wise P, Bauer J, Techner L.
Gastrointestinal recovery after laparoscopic colectomy: results of a
prospective, observational, multicenter study. Surg Endosc.
2010;24(3):653–61.
9. Champagne BJ, Delaney CP. Laparoscopic approaches to rectal
cancer. Clin Colon Rectal Surg. 2007;20(3):237–48.
10. Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ,
et al. Laparoscopic surgery versus open surgery for colon cancer:
short-term outcomes of a randomised trial. Lancet Oncol. 2005;6(7):
477–84.
11. Delaney CP, Chang E, Senagore AJ, Broder M. Clinical outcomes and
resource utilization associated with laparoscopic and open colectomy
using a large national database. Ann Surg. 2008;247(5):819–24.
12. Champagne BJ, Makhija R. Minimally invasive surgery for rectal
cancer: are we there yet? World J Gastroenterol. 2011;17(7):862–6.
13. Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM,
et al. Randomized trial of laparoscopic-assisted resection of
colorectal carcinoma: 3-year results of the UK MRC CLASICC
Trial Group. J Clin Oncol. 2007;25(21):3061–8.
14. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou
PJ. Five-year follow-up of the Medical Research Council CLASICC
trial of laparoscopically assisted versus open surgery for colorectal
cancer. Br J Surg. 2010;97(11):1638–45.
15. Aziz O, Constantinides V, Tekkis PP, Athanasiou T, Purkayastha S,
Paraskeva P, et al. Laparoscopic versus open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol. 2006;13(3):413–24.
16. Baik SH, Gincherman M, Mutch MG, Birnbaum EH, Fleshman JW.
Laparoscopic vs open resection for patients with rectal cancer:
comparison of perioperative outcomes and long-term survival. Dis
Colon Rectum. 2011;54(1):6–14.
17. Gao F, Cao YF, Chen LS. Meta-analysis of short-term outcomes
after laparoscopic resection for rectal cancer. Int J Colorectal Dis.
2006;21(7):652–6.
18. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al.
Short-term endpoints of conventional versus laparoscopic- assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365(9472):1718–26.
19. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al.
Open versus laparoscopic surgery for mid or low rectal cancer after
neoadjuvant chemoradiotherapy (COREAN trial): short- term outcomes of an open-label randomised controlled trial. Lancet Oncol.
2010;11(7):637–45.
20. Laurent C, Leblanc F, Gineste C, Saric J, Rullier E. Laparoscopic
approach in surgical treatment of rectal cancer. Br J Surg.
2007;94(12):1555–61.
21. Lelong B, Bege T, Esterni B, Guiramand J, Turrini O, Moutardier
V, et al. Short-term outcome after laparoscopic or open restorative
mesorectal excision for rectal cancer: a comparative cohort study.
Dis Colon Rectum. 2007;50(2):176–83.
22. Leung KL, Lai PB, Ho RL, Meng WC, Yiu RY, Lee JF, et al.
Systemic cytokine response after laparoscopic-assisted resection of
rectosigmoid carcinoma: a prospective randomized trial. Ann Surg.
2000;231(4):506–11.
23. Lujan J, Valero G, Hernandez Q, Sanchez A, Frutos MD, Parrilla P.
Randomized clinical trial comparing laparoscopic and open surgery
in patients with rectal cancer. Br J Surg. 2009;96(9):982–9.
24. Ng SS, Leung KL, Lee JF, Yiu RY, Li JC, Teoh AY, et al.
Laparoscopic-assisted versus open abdominoperineal resection for
low rectal cancer: a prospective randomized trial. Ann Surg Oncol.
2008;15(9):2418–25.
25. Ng SS, Leung KL, Lee JF, Yiu RY, Li JC, Hon SS. Long-term morbidity and oncologic outcomes of laparoscopic-assisted anterior
resection for upper rectal cancer: ten-year results of a prospective,
randomized trial. Dis Colon Rectum. 2009;52(4):558–66.
26. Anderson C, Uman G, Pigazzi A. Oncologic outcomes of laparoscopic surgery for rectal cancer: a systematic review and metaanalysis of the literature. Eur J Surg Oncol. 2008;34(10):
1135–42.
27. Huang MJ, Liang JL, Wang H, Kang L, Deng YH, Wang JP.
Laparoscopic-assisted versus open surgery for rectal cancer: a
meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes. Int J
Colorectal Dis. 2011;26(4):415–21.
28. Ohtani H, Tamamori Y, Azuma T, Mori Y, Nishiguchi Y, Maeda K,
et al. A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and con-

498
D.S. Keller and C.P. Delaney
ventional open surgery for rectal cancer. J Gastrointest Surg.
2011;15(8):1375–85.
29. Choi DH, Jeong WK, Lim SW, Chung TS, Park JI, Lim SB, et al.
Learning curves for laparoscopic sigmoidectomy used to manage
curable sigmoid colon cancer: single-institute, three-surgeon experience. Surg Endosc. 2009;23(3):622–8.
30. Pandey S, Slawik S, Cross K, Soulsby R, Pullyblank AM, Dixon
AR. Laparoscopic appendicectomy: a training model for laparoscopic right hemicolectomy? Colorectal Dis. 2007;9(6):536–9.
31. Tekkis PP, Senagore AJ, Delaney CP. Conversion rates in laparoscopic colorectal surgery: a predictive model with, 1253 patients.
Surg Endosc. 2005;19(1):47–54.
32. Wexner SD, Cohen SM. Port site metastases after laparoscopic
colorectal surgery for cure of malignancy. Br J Surg. 1995;82(3):
295–8.
33. Akiyoshi T, Kuroyanagi H, Ueno M, Oya M, Fujimoto Y, Konishi
T, et al. Learning curve for standardized laparoscopic surgery for
colorectal cancer under supervision: a single-center experience.
Surg Endosc. 2011;25(5):1409–14.
34. Li JC, Hon SS, Ng SS, Lee JF, Yiu RY, Leung KL. The learning
curve for laparoscopic colectomy: experience of a surgical fellow in
an university colorectal unit. Surg Endosc. 2009;23(7):1603–8.
35. Park IJ, Choi GS, Lim KH, Kang BM, Jun SH. Multidimensional
analysis of the learning curve for laparoscopic colorectal surgery:
lessons from 1,000 cases of laparoscopic colorectal surgery. Surg
Endosc. 2009;23(4):839–46.
36. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J,
et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl
Cancer Inst. 2001;93(8):583–96.
37. Row D, Weiser MR. An update on laparoscopic resection for rectal
cancer. Cancer Control. 2010;17(1):16–24.
38. Kavic MS. Hand-assisted laparoscopic surgery–HALS. JSLS.
2001;5(2):101–3.
39. Hand-assisted laparoscopic surgery vs standard laparoscopic surgery for colorectal disease: a prospective randomized trial. HALS
Study Group. Surg Endosc. 2000;14(10):896–901.
40. Meijer DW, Bannenberg JJ, Jakimowicz JJ. Hand-assisted laparoscopic surgery: an overview. Surg Endosc. 2000;14(10):891–5.
41. Leblanc F, Delaney CP, Neary PC, Rose J, Augestad KM, Senagore
AJ, et al. Assessment of comparative skills between hand-assisted
and straight laparoscopic colorectal training on an augmented reality simulator. Dis Colon Rectum. 2010;53(9):1323–7.
42. Cima RR, Pattana-arun J, Larson DW, Dozois EJ, Wolff BG,
Pemberton JH. Experience with 969 minimal access colectomies: the
role of hand-assisted laparoscopy in expanding minimally invasive surgery for complex colectomies. J Am Coll Surg. 2008;206(5):946–50;
discussion 950–2.
43. Asgeirsson T, Delaney CP. Laparoscopic proctectomy: oncologic
considerations. Surg Laparosc Endosc Percutan Tech. 2012;22(3):
175–9.
44. Alasari S, Min BS. Robotic colorectal surgery: a systematic review.
ISRN Surg. 2012;2012:293894.
45. Baik SH. Robotic colorectal surgery. Yonsei Med J. 2008;49(6):891–6.
46. Abbou CC, Hoznek A, Salomon L, Olsson LE, Lobontiu A, Saint F,
et al. Laparoscopic radical prostatectomy with a remote controlled
robot. J Urol. 2001;165(6 Pt 1):1964–6.
47. Kong SH, Oh BM, Yoon H, Ahn HS, Lee HJ, Chung SG, et al.
Comparison of two- and three-dimensional camera systems in laparoscopic performance: a novel 3D system with one camera. Surg
Endosc. 2010;24(5):1132–43.
48. Ostrowitz MB, Eschete D, Zemon H, DeNoto G. Robotic-assisted
single-incision right colectomy: early experience. Int J Med Robot.
2009;5(4):465–70.
49. Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP. Short-term clinical
outcome of robot-assisted intersphincteric resection for low rectal
cancer: a retrospective comparison with conventional laparoscopy.
Surg Endosc. 2013;27:48–55.
50. Ahmed K, Ibrahim A, Wang TT, Khan N, Challacombe B, Khan
MS, et al. Assessing the cost effectiveness of robotics in urological
surgery – a systematic review. BJU Int. 2012;110:1544–56.
51. Kim JY, Kim NK, Lee KY, Hur H, Min BS, Kim JH. A comparative study of voiding and sexual function after total mesorectal
excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol. 2012;19(8):
2485–93.
52. Morino M, Parini U, Allaix ME, Monasterolo G, Brachet Contul R,
Garrone C. Male sexual and urinary function after laparoscopic
total mesorectal excision. Surg Endosc. 2009;23(6):1233–40.
53. Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H, et al. Robot- assisted
versus conventional laparoscopic surgery for colorectal disease,
focusing on rectal cancer: a meta-analysis. Ann Surg Oncol. 2012;
19:3727–36.
54. Ortiz-Oshiro E, Sanchez-Egido I, Moreno-Sierra J, Perez CF, Diaz
JS, Fernandez-Represa JA. Robotic assistance may reduce conversion to open in rectal carcinoma laparoscopic surgery: systematic
review and meta-analysis. Int J Med Robot. 2012;8:360–70.
55. Memon S, Heriot AG, Murphy DG, Bressel M, Lynch AC. Robotic
versus laparoscopic proctectomy for rectal cancer: a meta- analysis.
Ann Surg Oncol. 2012;19(7):2095–101.
56. Trastulli S, Farinella E, Cirocchi R, Cavaliere D, Avenia N,
Sciannameo F, et al. Robotic resection compared with laparoscopic
rectal resection for cancer: systematic review and meta- analysis of
short-term outcome. Colorectal Dis. 2012;14(4):e134–56.
57. Baik SH, Kwon HY, Kim JS, Hur H, Sohn SK, Cho CH, et al.
Robotic versus laparoscopic low anterior resection of rectal cancer:
short-term outcome of a prospective comparative study. Ann Surg
Oncol. 2009;16(6):1480–7.
58. Kim KY, Hwang DW, Park YK, Lee HS. A single surgeon’s experience with 54 consecutive cases of multivisceral resection for locally
advanced primary colorectal cancer: can the laparoscopic approach
be performed safely? Surg Endosc. 2012;26(2):493–500.
59. Jayne DG, Brown JM, Thorpe H, Walker J, Quirke P, Guillou PJ.
Bladder and sexual function following resection for rectal cancer in
a randomized clinical trial of laparoscopic versus open technique.
Br J Surg. 2005;92(9):1124–32.
60. Lin S, Jiang HG, Chen ZH, Zhou SY, Liu XS, Yu JR. Meta- analysis
of robotic and laparoscopic surgery for treatment of rectal cancer.
World J Gastroenterol. 2011;17(47):5214–20.
61. Collinson FJ, Jayne DG, Pigazzi A, Tsang C, Barrie JM, Edlin R,
et al. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus
standard laparoscopic surgery for the curative treatment of rectal
cancer. Int J Colorectal Dis. 2012;27(2):233–41.
62. Zimmern A, Prasad L, Desouza A, Marecik S, Park J, Abcarian H.
Robotic colon and rectal surgery: a series of 131 cases. World J
Surg. 2010;34:1954–58.
63. Abodeely A, Lagares-Garcia JA, Duron V, Vrees M. Safety and
learning curve in robotic colorectal surgery. Robot Surg
2010;4(3):161–5.
64. Ragupathi M, Ramos-Valadez DI, Patel CB, Haas EM. Roboticassisted laparoscopic surgery for recurrent diverticulitis: experience
in consecutive cases and a review of the literature. Surg Endosc.
2011;25:199–206.
65. de Hoog DE, Heemskerk J, Nieman FH, van Gemert WG, Baeten
CG, Bouvy ND. Recurrence and functional results after open versus conventional laparoscopic versus robot-assisted laparoscopic
rectopexy for rectal prolapse: a case-control study. Int J Colorectal
Dis. 2009;24:1201–6.
66. Bokhari MB, Patel CB, Ramos-Valadez DI, Ragupathi M, Haas
EM. Learning curve for robotic-assisted laparoscopic colorectal
surgery. Surg Endosc. 2011;25:855–60.
67. de Souza AL, Prasad LM, Park JJ, Marecik SJ, Blumetti J, Abcarian
H. Robotic assistance in right hemicolectomy: is there a role? Dis
Colon Rectum 2010;53(7):1000–6.

32 Laparoscopy, Robotics, and Endoscopy
499
68. Luca F, Ghezzi TL, Valvo M et al. Surgical and pathological outcomes after right hemicolectomy: case-matched study comparing
robotic and open surgery. Int J Med Robot. 2011 May 11. doi:
10.1002/rcs.398 . [Epub ahead of print].
69. D’Annibale A, Morpurgo E, Fiscon V, Trevisan P, Sovernigo G,
Orsini C, et al. Robotic and laparoscopic surgery for treatment of
colorectal diseases. Dis Colon Rectum. 2004;47(12):2162–8.
70. Delaney CP, Lynch AC, Senagore AJ, Fazio VW. Comparison of
robotically performed and traditional laparoscopic colorectal surgery. Dis Colon Rectum. 2003;46(12):1633–9.
71. Delaney CP, Senagore AJ, Ponsky L. Robot-assisted surgery and
health care costs. N Engl J Med. 2010;363(22):2175; author reply
2176.
72. Barbash GI, Glied SA. New technology and health care costs–the
case of robot-assisted surgery. N Engl J Med. 2010;363(8):701–4.
73. Wright JD, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut
AI, et al. Robotically assisted vs laparoscopic hysterectomy
among women with benign gynecologic disease. JAMA. 2013;
309(7):689–98.
74. Citron intuitive surgical’s bad day in court: trial proceeds in three
weeks. 2013. Available Online at
wp-content/uploads/2013/03/Intuitive-Surgical-Taylor-caseupdate- fi nal.pdf
75. Breeden JT. Statement on robotic surgery by the American
College of Obstetricians and Gynecologists. 2013. Available
Online at
News_Releases/2013/Statement_on_Robotic_Surgery
76. Jin LX, Ibrahim AM, Newman NA, Makarov DV, Pronovost PJ,
Makary MA. Robotic surgery claims on United States hospital
websites. J Healthc Qual. 2011;33(6):48–52.
77. Citron research reports on intuitive surgical: has the halo been broken on intuitive surgical? 2012. Available Online at
citronresearch.com/wp-content/uploads/2012/12/isrg- fi nal1.pdf
78. Piskun G, Rajpal S. Transumbilical laparoscopic cholecystectomy
utilizes no incisions outside the umbilicus. J Laparoendosc Adv
Surg Tech A. 1999;9(4):361–4.
79. Remzi FH, Kirat HT, Kaouk JH, Geisler DP. Single-port laparoscopy in colorectal surgery. Colorectal Dis. 2008;10(8):823–6.
80. Bucher P, Pugin F, Morel P. Single port access laparoscopic right
hemicolectomy. Int J Colorectal Dis. 2008;23(10):1013–6.
81. Papaconstantinou HT, Sharp N, Thomas JS. Single-incision laparoscopic right colectomy: a case-matched comparison with standard laparoscopic and hand-assisted laparoscopic techniques. J
Am Coll Surg. 2011;213(1):72–80; discussion 80–2.
82. Kim SJ, Ryu GO, Choi BJ, Kim JG, Lee KJ, Lee SC, et al. The
short-term outcomes of conventional and single-port laparoscopic
surgery for colorectal cancer. Ann Surg. 2011;254(6):933–40.
83. Adair J, Gromski MA, Lim RB, Nagle D. Single-incision laparoscopic right colectomy: experience with 17 consecutive cases and
comparison with multiport laparoscopic right colectomy. Dis
Colon Rectum. 2010;53(11):1549–54.
84. Champagne BJ, Papaconstantinou HT, Parmar SS, Nagle DA,
Young-Fadok TM, Lee EC, et al. Single-incision versus standard
multiport laparoscopic colectomy: a multicenter, case-controlled
comparison. Ann Surg. 2012;255(1):66–9.
85. Chen WT, Chang SC, Chiang HC, Lo WY, Jeng LB, Wu C, et al.
Single-incision laparoscopic versus conventional laparoscopic
right hemicolectomy: a comparison of short-term surgical results.
Surg Endosc. 2011;25(6):1887–92.
86. Huscher CG, Mingoli A, Sgarzini G, Mereu A, Binda B, Brachini
G, et al. Standard laparoscopic versus single-incision laparoscopic
colectomy for cancer: early results of a randomized prospective
study. Am J Surg. 2012;204(1):115–20.
87. Vasilakis V, Clark CE, Liasis L, Papaconstantinou HT.
Noncosmetic benefi ts of single-incision laparoscopic sigmoid colectomy for diverticular disease: A case-matched comparison with
multiport laparoscopic technique. J Surg Res. 2013;180:201–7.
.
http://www.acog.org/About_ACOG/News_Room/
http://www.citronresearch.com/
.
http://www.
.
88. Chambers WM, Bicsak M, Lamparelli M, Dixon AR. Singleincision laparoscopic surgery (SILS) in complex colorectal surgery: a technique offering potential and not just cosmesis.
Colorectal Dis. 2011;13(4):393–8.
89. Bulut O, Nielsen CB, Jespersen N. Single-port access laparoscopic surgery for rectal cancer: initial experience with 10 cases.
Dis Colon Rectum. 2011;54(7):803–9.
90. Poon JT, Cheung CW, Fan JK, Lo OS, Law WL. Single-incision
versus conventional laparoscopic colectomy for colonic neoplasm: a randomized, controlled trial. Surg Endosc. 2012;26(10):
2729–34.
91. Merchant AM, Cook MW, White BC, Davis SS, Sweeney JF, Lin
E. Transumbilical Gelport access technique for performing single
incision laparoscopic surgery (SILS). J Gastrointest Surg. 2009;
13(1):159–62.
92. Gaujoux S, Bretagnol F, Ferron M, Panis Y. Single-incision laparoscopic colonic surgery. Colorectal Dis. 2011;13(9):1066–71.
93. Champagne BJ, Lee EC, Leblanc F, Stein SL, Delaney CP. Singleincision vs straight laparoscopic segmental colectomy: a casecontrolled study. Dis Colon Rectum. 2011;54(2):183–6.
94. Park JS, Choi GS, Park SY, Kim HJ, Ryuk JP. Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg. 2012;99(9):1219–26.
95. Pucher PH, Sodergren MH, Singh P, Darzi A, Parakseva P. Have
we learned from lessons of the past? A systematic review of
training for single incision laparoscopic surgery. Surg Endosc.
2013;27:1478–84.
96. Delaney CP, Champagne BJ, Marks JM, Sanuk L, Ermlich B,
Chak A. Tissue apposition system: new technology to minimize
surgery for endoscopically unresectable colonic polyps. Surg
Endosc. 2010;24(12):3113–8.
97. Nelson DB, Block KP, Bosco JJ, Burdick JS, Curtis WD, Faigel
DO, et al. Endoscopic mucosal resection: May 2000. Gastrointest
Endosc. 2000;52(6 Pt 1):860–3.
98. Repici A, Pellicano R, Strangio G, Danese S, Fagoonee S, Malesci
A. Endoscopic mucosal resection for early colorectal neoplasia:
pathologic basis, procedures, and outcomes. Dis Colon Rectum.
2009;52(8):1502–15.
99. Iishi H, Tatsuta M, Iseki K, Narahara H, Uedo N, Sakai N, et al. Endoscopic
piecemeal resection with submucosal saline injection of large sessile
colorectal polyps. Gastrointest Endosc. 2000;51(6):697–700.
100. Saito Y, Fukuzawa M, Matsuda T, Fukunaga S, Sakamoto T, Uraoka
T, et al. Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal resection of large colorectal tumors as determined by curative resection. Surg Endosc. 2010;24(2):343–52.
101. Tanaka S, Haruma K, Oka S, Takahashi R, Kunihiro M, Kitadai Y,
et al. Clinicopathologic features and endoscopic treatment of
superfi cially spreading colorectal neoplasms larger than 20 mm.
Gastrointest Endosc. 2001;54(1):62–6.
102. Holt BA, Bourke MJ. Wide fi eld endoscopic resection for
advanced colonic mucosal neoplasia: current status and future
directions. Clin Gastroenterol Hepatol. 2012;10(9):969–79.
103. Puli SR, Kakugawa Y, Gotoda T, Antillon D, Saito Y, Antillon MR.
Meta-analysis and systematic review of colorectal endoscopic
mucosal resection. World J Gastroenterol. 2009;15(34):4273–7.
104. Swan MP, Bourke MJ, Alexander S, Moss A, Williams SJ. Large
refractory colonic polyps: is it time to change our practice? A prospective study of the clinical and economic impact of a tertiary
referral colonic mucosal resection and polypectomy service (with
videos). Gastrointest Endosc. 2009;70(6):1128–36.
105. Tanaka S, Oka S, Kaneko I, Hirata M, Mouri R, Kanao H, et al.
Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization. Gastrointest Endosc. 2007;66(1):100–7.
106. Yamamoto H, Kawata H, Sunada K, Sasaki A, Nakazawa K,
Miyata T, et al. Successful en-bloc resection of large superfi cial
tumors in the stomach and colon using sodium hyaluronate and
small-caliber-tip transparent hood. Endoscopy. 2003;35(8):690–4.

500
D.S. Keller and C.P. Delaney
107. Steele SR. ASCRS core subject update 2011. Endoscopy/Polyps.
Available Online at: http://www.fascrs.org/physicians/education/
core_subjects/2011/Endoscopy
108. Chang DK. Current status of colorectal endoscopic submucosal
dissection in Korea. Clin Endosc. 2012;45(3):288–9.
109. Park SU, Min YW, Shin JU, Choi JH, Kim YH, Kim JJ, et al.
Endoscopic submucosal dissection or transanal endoscopic
microsurgery for nonpolypoid rectal high grade dysplasia and
submucosa- invading rectal cancer. Endoscopy. 2012;44:1031–6.
110. Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y,
Ono S, et al. Outcomes of endoscopic submucosal dissection for
colorectal epithelial neoplasms in 200 consecutive cases. Clin
Gastroenterol Hepatol. 2007;5(6):678–83. quiz 645.
111. Tamegai Y, Saito Y, Masaki N, Hinohara C, Oshima T, Kogure E,
et al. Endoscopic submucosal dissection: a safe technique for
colorectal tumors. Endoscopy. 2007;39(5):418–22.
112. Yoshida N, Naito Y, Sakai K, Sumida Y, Kanemasa K, Inoue K,
et al. Outcome of endoscopic submucosal dissection for colorectal
tumors in elderly people. Int J Colorectal Dis. 2010;25(4):455–61.
113. Lee BI. Indications, knives, and electric current: what’s the best?
Clin Endosc. 2012;45(3):285–7.
114. Huang C, Huang RX, Xiang P, Qiu ZJ. Current research status of
endoscopic submucosal dissection for colorectal neoplasms. Clin
Invest Med. 2012;35(4):E158.
115. Oka S, Tanaka S, Kanao H, Ishikawa H, Watanabe T, Igarashi M,
et al. Current status in the occurrence of postoperative bleeding,
perforation and residual/local recurrence during colonoscopic
treatment in Japan. Dig Endosc. 2010;22(4):376–80.
116. Agrawal D, Chak A, Champagne BJ, Marks JM, Delaney CP.
Endoscopic mucosal resection with full-thickness closure for diffi cult polyps: a prospective clinical trial. Gastrointest Endosc.
2010;71(6):1082–8.
117. Wood JJ, Lord AC, Wheeler JM, Borley NR. Laparo-endoscopic
resection for extensive and inaccessible colorectal polyps: a feasible and safe procedure. Ann R Coll Surg Engl. 2011;93(3):241–5.
118. Tekkis PP, Poloniecki JD, Thompson MR, Stamatakis JD.
Operative mortality in colorectal cancer: prospective national
study. BMJ. 2003;327(7425):1196–201.
119. Franklin MEJ, Leyva-Alvizo A, Abrego-Medina D, Glass JL,
Trevino J, Arellano PP, et al. Laparoscopically monitored colonoscopic polypectomy: an established form of endoluminal therapy
for colorectal polyps. Surg Endosc. 2007;21(9):1650–3.
120. Hensman C, Luck AJ, Hewett PJ. Laparoscopic-assisted colonoscopic polypectomy: technique and preliminary experience. Surg
Endosc. 1999;13(3):231–2.
121. Mal F, Perniceni T, Levard H, Boudet MJ, Levy P, Gayet B.
Colonic polyps considered unresectable by endoscopy. Removal
by combinations of laparoscopy and endoscopy in 65 patients.
Gastroenterol Clin Biol. 1998;22(4):425–30.
122. Smedh K, Skullman S, Kald A, Anderberg B, Nystrom P.
Laparoscopic bowel mobilization combined with intraoperative
colonoscopic polypectomy in patients with an inaccessible polyp
of the colon. Surg Endosc. 1997;11(6):643–4.
123. Winter H, Lang RA, Spelsberg FW, Jauch KW, Huttl TP.
Laparoscopic colonoscopic rendezvous procedures for the treatment of polyps and early stage carcinomas of the colon. Int J
Colorectal Dis. 2007;22(11):1377–81.
. Accessed October 2013.
124. Grunhagen DJ, van Ierland MC, Doornebosch PG, Bruijninckx
MM, Winograd R, de Graaf EJ. Laparoscopic-monitored colonoscopic polypectomy: a multimodality method to avoid segmental
colon resection. Colorectal Dis. 2011;13(11):1280–4.
125. Wilhelm D, von Delius S, Weber L, Meining A, Schneider A,
Friess H, et al. Combined laparoscopic-endoscopic resections of
colorectal polyps: 10-year experience and follow-up. Surg Endosc.
2009;23(4):688–93.
126. Keehan SP, Cuckler GA, Sisko AM, Madison AJ, Smith SD,
Lizonitz JM, et al. National health expenditure projections: modest annual growth until coverage expands and economic growth
accelerates. Health Aff (Millwood). 2012;31(7):1600–12.
127. Davis K. Toward a high performance health system: the
Commonwealth Fund’s new commission. Health Aff (Millwood).
2005;24(5):1356–60.
128. Klarenbeek BR, Bergamaschi R, Veenhof AA, van der Peet DL,
van den Broek WT, de Lange ES, et al. Laparoscopic versus open
sigmoid resection for diverticular disease: follow-up assessment
of the randomized control Sigma trial. Surg Endosc. 2011;25(4):
1121–6.
129. Shabbir A, Roslani AC, Wong KS, Tsang CB, Wong HB, Cheong
WK. Is laparoscopic colectomy as cost benefi cial as open colectomy? ANZ J Surg. 2009;79(4):265–70.
130. Musser DJ, Boorse RC, Madera F, Reed 3rd JF. Laparoscopic colectomy: at what cost? Surg Laparosc Endosc. 1994;4(1):1–5.
131. Hayes JL, Hansen P. Is laparoscopic colectomy for cancer costeffective relative to open colectomy? ANZ J Surg. 2007;77(9):
782–6.
132. Abraham NS, Young JM, Solomon MJ. Meta-analysis of shortterm outcomes after laparoscopic resection for colorectal cancer.
Br J Surg. 2004;91(9):1111–24.
133. Braga M, Frasson M, Zuliani W, Vignali A, Pecorelli N, Di Carlo
V. Randomized clinical trial of laparoscopic versus open left
colonic resection. Br J Surg. 2010;97(8):1180–6.
134. Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJ. Fast
track surgery versus conventional recovery strategies for
colorectal surgery. Cochrane Database Syst Rev. 2011;(2):
CD007635.
135. Vlug MS, Wind J, Hollmann MW, Ubbink DT, Cense HA, Engel
AF, et al. Laparoscopy in combination with fast track multimodal
management is the best perioperative strategy in patients undergoing colonic surgery: a randomized clinical trial (LAFA-study).
Ann Surg. 2011;254(6):868–75.
136. Delaney CP, Brady K, Woconish D, Parmar SP, Champagne BJ.
Towards optimizing perioperative colorectal care: outcomes for 1,000
consecutive laparoscopic colon procedures using enhanced recovery
pathways. Am J Surg. 2012;203(3):353–5; discussion 355–6.
137. Jensen CC, Prasad LM, Abcarian H. Cost-effectiveness of laparoscopic vs open resection for colon and rectal cancer. Dis Colon
Rectum. 2012;55(10):1017–23.
138. Fox J, Gross CP, Longo W, Reddy V. Laparoscopic colectomy for
the treatment of cancer has been widely adopted in the United
States. Dis Colon Rectum. 2012;55(5):501–8.
139. Leddy LS, Lendvay TS, Satava RM. Robotic surgery: applications
and cost effectiveness. Open Access Surg. 2010;3:99–107.
140. Uno Y, Munakata A. The non-lifting sign of invasive colon cancer.
Gastrointest Endosc. 1994;40(4):485–9.

Technical Aspects
Bradley Davis and Janice F. Rafferty
3 3
Key Points
• While several anastomotic techniques are utilized,
adhering to the traditional principles of proper tissue handling, ensuring adequate blood supply, and
avoiding tension remain essential to optimizing
outcomes.
• Methods for creating adequate length for a technically sound left-sided bowel anastomosis include
proper mobilization of the splenic fl exure and
mesentery, division of the inferior mesenteric vein
near the ligament of Treitz, ligation of the inferior
mesenteric artery, and rectal mobilization (when
applicable).
• You should have a stepwise and thorough algorithm
for troubleshooting the diffi cult anastomosis.
• With more operations being performed through
minimally invasive approaches, laparoscopic techniques for mobilizing the colon and maintaining optimal visualization are vital to minimizing
complications.
• Leak testing is a critical component to left-sided
anastomoses, and you should understand what to do
with a positive leak test or incomplete donuts.
Introduction
The practice of surgery requires a broad, yet fl exible skill set
that allows a surgeon to adapt to increasingly complex procedures. Every operative case represents an opportunity to be
challenged mentally and technically. Furthermore, every surgeon is faced with the fundamental question at some point in
their career: what will it take to get this patient off of the table?
Whether it is a hostile reoperative abdomen (see Video 33.1 ,
Courtesy of Amir Bastawrous, MD) or a stapler misfi re on a
low rectal cancer, there are situations in the operating room
that are low frequency but high acuity that require an optimal
breadth and depth of skills and sound decision-making. In this
chapter, we specifi cally review these infrequent technical challenges and offer an approach that has been successful in our
practice. Although there will not always be randomized controlled trials to show us the way, when there is experience in the
literature, we will attempt to bring it to light. Unfortunately, this
is frequently the case when confronted with these situations,
and we must rely on our experience, that of others, and the
small amount of available evidence to guide our management.
Intestinal Anastomosis
Stapled Versus Hand Sewn and Single Versus Double Layer
Key Concept : The success of a technically perfect anastomosis is not dependent on whether the bowel is stapled or hand
sewn ( single or double layer ).
Numerous studies have attempted to defi ne the characteristics of the perfect anastomosis, and while the technique
has largely been standardized, there remains an ever-present
risk of failure with signifi cant consequences to the patient.
In modern surgical practice, the choice of suture or staples
(and how to use them) has been shown to make little difference in anastomotic success or failure. In reality, few
studies have ever shown superiority of one over the other.
The most recent Cochrane review [ 1 ], published in 2012,
was an update of a previous meta-analysis [
the results of 1,233 patients undergoing colorectal resec-
2 ] and analyzed
B. Davis , MD • J. F. Rafferty , MD (*)
Division of Colon and Rectal Surgery, Department of Surgery,
University of Cincinnati , Cincinnati , OH , USA
e-mail: davisbd@ucmail.uc.edu; janice.rafferty@uc.edu
S.R. Steele et al. (eds.), Complexities in Colorectal Surgery,
DOI 10.1007/978-1-4614-9022-7_33, © Springer Science+Business Media New York 2014
The online version of this chapter (doi: 10.1007/978-1-4614-9022-
) contains supplementary material, which is available to
7_33
authorized users.
501
Соседние файлы в папке Библиотека им академика М.И. Перельмана
